Fig. 4: Comparison of immune responses between variant vaccine and prorotype vaccine in BALB/c mice. | npj Vaccines

Fig. 4: Comparison of immune responses between variant vaccine and prorotype vaccine in BALB/c mice.

From: A potent, broadly protective vaccine against SARS-CoV-2 variants of concern

Fig. 4

A Pseudovirus neutralizing antibody titers (GMT ± 95%CI) against prototype SARS-CoV-2, Beta strain, and Delta strain at day 35. B Results (mean ± SD) of S-specific ELISPOT at day 35. Note: *p < 0.05; ****p < 0.0001.

Back to article page